Supernus Pharmaceuticals Inc’s filing revealed that its Director Sensenig Bethany unloaded Company’s shares for reported $0.23 million on Aug 14
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Supernus Pharmaceuticals
Supernus Pharmaceuticals Inc’s recently made public that its President, CEO Khattar Jack A. unloaded Company’s shares for reported $5.88 million
Supernus Pharmaceuticals Inc’s recently made public that its SVP, Chief Medical Officer Rubin Jonathan unloaded Company’s shares for reported $36292.0
Supernus Pharmaceuticals Inc’s recent filing unveils that its SVP, Chief Medical Officer Rubin Jonathan unloaded Company’s shares for reported $36292.0